диссертации / 98

201

84.Frade J.M., Rodriguez-Tebar A., Barde Y.A. Induction of cell death by endogenous nerve growth factor through its p75 receptor // Nature. – 1996; 383: 166– 8.

85.Freyschmidt-Paul P. et al. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice // J. Investig. Dermatol. Symp. – 2003; 8: 104–8.

86.Freyschmidt-Paul P., Happle R., McElwee K.J. et al. Alopecia areata: treatment today and potential treatmens of tomorrow // J. Invest. Dermatol. Symp. Proc. – 2003; 8: 12–7.

87.Freyschmidt-Paul P., Hoffman R., Levine E. et al. Current and potential agents for the treatment of alopecia areata // Curr. Pharm. Des. – 2001; 7: 213–30.

88.Freyschmidt-Paul P.M.K., Hoffmann R., McElwee J.K. Alopecia areata. In: Hair growth and disorders. Eds. Blume-Peytavi U., Whiting D.A., Tosti A., Trueb R.

/Berlin: Springer, 2008; 311–20.

89.Fujita A., Kurachi Y. SAP family proteins // Biochem. Biophys. Res. Commun. – 2000; 269: 1–6.

90.Galbraith G.M., Palesch Y., Gore E.A. et al. Contribution of interleukin 1

beta and KM loci to alopecia areata // Hum. Hered. – 1999; 49: 85–9.

91.Galbreith G.M., Pandey J.P. Km1 allotype association with one subgroup of alopecia areata // Am. J. Hum. Genet. – 1989; 44: 426–8.

92.Galbreith G.M., Pandey J.P. Tumor necrosis factor alpha (TNF-alpha) gene polymorphisms in alopecia areata // Hum Genet. – 1995; 96: 433–6.

93.Galbreith G.M., Thiers B.H., Pandey J.P. Gm allotype associated resistance and susceptibility to alopecia areata // Clin. Exp. Immunol. – 1984; 56: 149–52.

202

94.Gandarillas A., Goldsmith L.A., Gschmeissner S. et al. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes // Exp. Dermatol. – 1999; 8: 71–9.

95.Garcia Bartels N., Lee H.H., Worm M. et al. Development of alopecia areata universalis in a patient receiving adalimumab // Arch. Dermatol. – 2006; 142 (12): 1654–5.

96.García-Hernández M.J., Torres M.J., Palomares J.C. et al. No evidence of cytomegalovirus DNA in alopecia areata // J. Invest. Dermatol. – 1998; 110 (2): 185.

97.Gavrieli Y., Sherman Y., Bensasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation // J. Cell Biol. – 1992; 119: 493–501.

98.Gilhar A., Kalish R.S. Alopecia areata: a tissue specific autoimmune disease of the hair follicle // Autoimmun. Rev. – 2006; 5: 64–9.

99.Gilhar A., Paus R., Kalish R.S. Lymphocytes, neuropeptides, and genes involved in alopecia areata // J. Clin. Invest. – 2007; 117: 2019–27.

100.Gilhar A., Pillar T., Etzioni A. Topical cyclosporine in male pattern alopecia // J. Am. Acad. Dermatol. – 1990; 22: 251–3.

101.Gip L., Lodin A., Molin L. Alopecia areata // Arch. Dermatol. – 1963; 88:

290–7.

102.Goh C., Finkel M., Christos P.J. et al. Profile of 513 patients with alopecia areata: assotiations of disease subtypes with atopy, autoimmune disease and positive family history // J. Eur. Acad. Dermatol. Venereol. – 2006; 20: 1055–60.

103.Goldman C.K., Tsai J.C., Soroceanu L. et al. Loss of vascular endothelial

ciclosporin in immune-mediated dermatoses // Br. J. Dermatol. – 2006; 155 (2): 1– 16.

203

105.Guijarro J., Silvestre J.F., Ramon R.L. et al. A peculiar pattern of alopecia

//Arch. Dermatol. – 2001; 137: 365–70.

106.Gupta A., Ellis C., Cooper K. et al. Oral cyclosporin for the treatment of alopecia areata. A clinical and immunohistochemical analysis // J. Am. Acad. Dermatol. – 1990; 22: 242.

107.Hacham-Zadeh S., Brautbar C., Cohen C.A. et al. HLA and alopecia areata in Jerusalem // Tissue Antigens. – 1981; 18 (1): 71–4.

108.Happle R., Hoffmann R. Cytokine patterns in alopecia areata before and after topical immunotherapy // J. Invest. Dermatol. – 1995; 104 (5): 14–5.

109.Happle R., Kalveran K., Buchner U. et al. Contact allergy as a therapeutic tool for alopecia areata: Application of squaric acid dibutylester // Dermatologica. – 1980; 161: 289.

110.Hisa T., Tanigychi S., Kobayashi H. Apoptosis in normal skin // Acta Dermatol. Venereol. – 1995; 75: 412–35.

111.Hoffmann R., Wenzel E., Huth A. et al. Growth factor mRNA levels in alopecia areata before and afte treatment with the contact allergen diphenylcyclopropenone // Acta Dermato-Venereologica. – 1996; 76: 17–20.

112.Hordinsky M.K., Hallgren H., Nelson D. et al. Familial alopecia areata. HLA-antigens and autoantibody formation in an American family // Arch. Dermatol.

– 1984; 120: 464–8.

113.Insler M.S., Helm C.J. Alopecia areata including the cilia and eyebrows of two sisters // Ann. Ophthalmol. – 1989; 21: 451–3.

114.Ito T. et al. Collapse and restoration of MHC class–I–dependent immune privilege: exploiting the human hair follicle as a model // Am. J. Pathol. – 2004; 164: 623–34.

115.Ito T., Saathoff M., Nickoloff B.J. et al. Novel aspects of hair follicle immune privilege and their relevance to alopecia areata [Abstract] // J. Invest. Dermatol. – 2005; 124 (Suppl.): A103.

204

116.Jahoda C.A.B., Horne K.A., Oliver R.F. Induction of hair growth by implantation of cultured dermal papilla cells // Nature. – 1984; 311: 560–2.

117.Jones P.H., Harper S., Watt F.M. Stem cell fate and patterning in human epidermis // Cell. – 1995; 80: 83–93.

118.Jonuleit H., Schmitt E., Stassen M. et al. Identification and functional characterization of human CD4(+)CD25(+) T-cells with regulatory properties isolated from peripheral blood // J. Exp. Med. – 2001; 193: 1285–94.

119.Kari J.A., Trompeter R.S. What is the calcineurin inhibitor of choice for pediatric renal transplantation? // Pediatr. Transplant. – 2004; 8: 437–44.

120.Katsuoka K. Clinical and basic approach for the treatment of alopecia areata. First World hair research congress (Abstracts) // Seville. – 1997; p.44.

121.Kianto U., Reunala T., Karvonen J. et al. HLA-B12 in alopecia areata // Arch. Dermatol. – 1977; 113 (12): 1716.

122.Kim B.J., Seong Uk Min, Kui Young Park et al. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata // J. Dermatol. Treatment. – 2008; 19 (4): 216–20.

123.Kim C.D., Lee M.-H., Sohn K.-C. et al. Induction of synapse associated protein 102 expression in cyclosporin A-stimulated hair growth // Exp. Dermatol. – 2008; 17: 693–9.

124.Kirshen C., Kanigsberg N. Alopecia areata following adalimumab // J. Cutan. Med. Surg. – 2009; 13 (1): 48–50.

125.Kishimoto S., Magata M., Takenaka H. et al. Detection of programmed cell death in anagen hair follicles of guinea pig skin by labeling of nick ends of fragmented DNA // Arch. Dermatol. Res. – 1997; 289: 603–5.

126.Knudson C.M., Korsmeyer S.J. Bcl-2 and Bax function independently to regulate cell death // Nature Genet. – 1997; 16: 358–63.

205

127.Kobayashi K., Rochat A., Barrandon Y. Segregation of keratinocyte colony-forming cells in the bulge of the rat vibrissa // Proc. Natl. Acad. Sci. USA. – 1993; 90: 7391–5.

128.Korsmeyer S.J. Bcl-2 gene family and the regulation of programmed cell death // Cancer Res. – 1999; 59 (7): 1693–700.

129.Kozlowska R., Blume-Peytavi U., Kodelja V. Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle

//Arch. Dermatol. Res. – 1998; 290: 661–8.

130.Kriegel M. et al. Defective suppressor function of human CD4+ CD25+ regulatory T-cells in autoimmune polyglandular syndrome type II // J. Exp. Med. – 2004; 199: 1285–91.

131.Kroemer G., Dallaporta B., Resche-Rigon M. The mitochrondrial death/life regulator in apoptosis and necrosis // Ann. Rev. Physiol. – 1998; 60: 619–42.

132.Kubeyinje E.P. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs // East. Afr. Med. J. – 1994; 71 (10): 674–5.

133.Kuga K., Nishifuji K., Iwasaki T. Cyclosporine A inhibits transcription of cytokine genes and decreases the frequencies of IL-2 producing cells in feline mononuclear cells // J. Vet. Med. Sci. – 2008; 70 (10): 1011–6.

134.Kurosawa M., Nakagawa S., Mizuashi M. et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata // Dermatology. – 2006; 212: 361–5.

135.Lachgar S., Charveron M., Gall Y. et al. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells // Br. J. Dermatol. – 1998; 138: 407–11.

136.Lane E.B., Wilson C.A., Hughes B.R. et al. Stem cells in hair follicles. Cytokeletal studies // Ann. NY Acad. Sci. – 1991; 642: 197–213.

137.Lassus A., Eskelinen A., Johansson E. Treatment of alopecia areata with three different PUVA modalities // Photodermatol. – 1984; 1 (3): 141–4.

206

138.Lebrun D.P., Warneke R.A., Cleary M.L. Expression of Bcl-2 in fetal tissues suggests a role in morphogenesis // Am. J. Pathol. – 1993; 142: 743–53.

139.Lee D., Hong S.K., Park S.W. et al. Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids // Exp. Dermatol. – 2010; 19 (2): 145–7.

140.Lee J.-R., Na S.-J., Choi G.-S. et al. The combination therapy of cyclosporine and methylprednisolone on severe alopecia areata: 3-year follow-up study // Int. J. Trichol. – 2009; 1 (1): 60.

141.Leung M.C., Fenton D.A., Sutton C.W. et al. Trichohyalin is a potential major autoantigen in human alopecia areata // J. Proteome Res. – 2010; 9 (10): 5153– 63.

142.Li A., Simmons P.J., Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype // Proc. Natl. Acad. Sci. USA. – 1998; 95: 3902–7.

143.Liberman A.C. et al. Glucocorticoids in the regulation of transcription factors that control cytokine synthesis // Cytokine Growth Factor Rev. – 2007; 18: 45–56.

144.Liberman A.C. et al. The activated glucocorticoid receptor inhibits the transcription factor Tbet by direct protein-protein interaction // FASEB. J. – 2007; 21: 1177–88.

145.Liberman A.C., Druker J., Garcia F.A. et al. Neuroimmunomodulation // Ann. N.Y. Acad. Sci. – 2009; 1153: 6–13.

146.Lichti U., Weinberg W.C., Goodman L. et al. In vivo regulation of murine hair growth: insights from grafting defined cell populations onto nude mice // J. Invest. Dermatol. – 1993; 101: 124–9.

147.Lindelof B., Larko O., Johannesson A. et al. PUVA an cancer risk: The Swedish follow-up study // B. J. Dermatol. – 1999; 141: 108–12.

207

148.Lindner G., Botchkarev V.A., Botchkareva N.V. et al. Analysis of apoptosis during hair follicle regression (catagen) // Am. J. Pathol. – 1997; 151: 1601–17.

149.Liu Y., Lyle S., Yang Z. et al. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge // J. Invest. Dermatol. – 2003; 121 (5): 963–8.

150.Lockskin R.A., Zakeri Z., Tilly J.L. When Dells Die // New York: WileyLiss, 1998.

151.Luger T. Treatment of immune-mediated skin diseases: future perspectives

//Eur. J. Dermatol. – 2001; 11: 343–7.

152.Lyle S., Christofidou-Solomidou M., Liu Y. et al. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells // J. Cell Sci. – 1998; 111: 3179–88.

153.MacDonald H.S.P., Wood M.L., Hutchinson P.E. et al. Guidelines for the management of alopecia areata // Br. J. Dermatol. – 2003; 149: 692–9.

154.Madan V., Griffiths C.E. Systemic ciclosporin and tacrolimus in dermatology // Dermatol. Ther. – 2007; 20 (4): 239–50.

155.Magerl M., Tobin D., Muller-Rover S. et al. Patterns of proliferation and apoptosis during murine hair follicle morphogenesis // J. Invest. Dermatol. – 2001; 116: 947–55.

156.Main R.A., Robbie R.B., Gray E.S. et al. Smooth muscle antibodies and alopecia areata // Br. J. Dermatol. – 1975; 92: 389–93.

157.Marie Y.S., Toulon A., Paus R., Maubec E. et al. Targeted Skin Overexpression of the Mineralocorticoid Receptor in Mice Causes Epidermal Atrophy, Premature Skin Barrier Formation, Eye Abnormalities, and Alopecia // Am. J. Pathol. – 2007; 171: 846–60.

208

158.Matic M., Taichman L., Simon M. A subset of K19 positive cells in the bulge of human hair follicles lack expression of GAP-junction protein Cx43 (Abstract) // J. Cell Biol. – 1998; 143: 94.

159.Matsuo K., Mori O., Hashimoto T. Apoptosis in murine hair follicles during catagen regression // Arch. Dermatol. Res. – 1998; 290: 133–6.

160.McDonagh A.J.G., Snowden J.A., Stierle C. et al. HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines // Br. J. Dermatol. – 1993; 129: 250–6.

161.McElwee K.J., Boggess D., King L.E. Jr. et al. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts // J. Invest. Dermatol. – 1998; 111: 797–803.

162.McElwee K.J., Pickett P., Oliver R.F. The DEBR rat, alopecia areata and autoantibodies to the hair follicle // Br. J. Dermatol. – 1996; 134 (1): 55–63.

163.McElwee K.J., Yu M., Park S.W. et al. What can we learn from animal models of Alopecia areata? // Dermatology. – 2005; 211: 47–53.

164.Mecklenburg L., Tobin D.J., Müller-Röver S. et al. Active Hair Growth (Anagen) is Associated with Angiogenesis // J. Invest. Dermatol. – 2000; 114: 909– 16.

165.Meisheri K.D., Johnson G.A., Puddington L. Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil // Biochem. Pharmacol. – 1993; 45: 271–9.

166.Molho-Pessach V., Ramor Y., Tenenbaum A. et al. Alopecia areata and Down syndrome: a coincidence? // J. Invest. Dermatol. – 2013; 133 (5): 1393

167.Moreno J.C., Ocaña M.S., Vélez A. Cyclosporin A and alopecia areata // J. Eur. Acad. Dermatol. Venereol. – 2002; 16 (4): 417–8.

168.Mori O., Uno H. The effect of topical minoxidil on hair follicular cycles of rats // J. Dermatol. – 1990; 17: 276–81.

209

169.Morris R.J., Potten C.S. Highly persistent label-retaining cells in the hair follicles of mice and their fate following induction of anagen // J. Invest. Dermatol. – 1999; 112: 470–5.

170.Morris R., Potten C. Slowly cycling (label-retaining) epidermal cells behave like clongenic stem cells in vitro // Cell Prolif. – 1994; 27: 279–89.

171.Mukuno A., Tsuboi H., Fujimura T. et al. CD4+ killer T cells are involved in the alopecia areata // JDDG. – 2004; 6 (band 2): 538.

172.Muller S.A., Winkelmann R.K. Alopecia areata: an evaluation of 736 patients // Arch. Dermatol. – 1963; 88: 290–7.

173.Muller-Rover S., Rossiter H., Lindner G. et al. Hair follicle apoptosis and Bcl-2 // J. Invest. Dermatol. Sympos. Proc. – 1999; 4: 272–7.

174.Nakaya Y., Hamaoka H., Kato S. et al. Effect of minoxidil sulfate and pinacidil on single potassium channel current in cultured human outer root sheath cells and dermal papilla cells // J. Dermatol. Sci. – 1994; 7 (Suppl): 104–8.

175.Narisawa Y., Hasimoto K., Kohda H. Epithelial skirt and bulge of human facial vellus hair follicles and associated Merkel cell-nerve complexes // Arch. Dermatol. Res. – 1993; 285: 269–77.

176.Neurath M.F. et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn’s disease // J. Exp. Med. – 2002; 195: 1129–43.

177.Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege // Nat. Immunol. – 2006; 7: 354–9.

178.Oliver R.F. Whisker growth after removal of the dermal papilla and lengths of follicle in the hooded rat // J. Embryol. Exp. Morphol. – 1966; 15: 331–47.

179.Olsen E. et al. Alopecia areata investigational assessment guidelines // J. Am. Acad. Dermatol. – 1999; 40 (1): 242–6.

180.Olsen E., Bergfeld W., Cotsarelis G. et al. Summary of North American Hair Research Society (NAHRS)-sponsored workshop in cicatricial alopecia, Duke

210

University Medical Center, February 10 and 11, 2001 // J. Am. Acad. Dermatol. – 2003; 48: 103–10.

181.Olsen E.A., Carson S.C., Turney E.A. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata // Arch. Dermatol. – 1992; 128 (11): 1467–73.

182.Olsen E.A., Hordinsky M.K., Price V. et al. Alopecia areata investigational assessment guidelines. Part II // J. Am. Acad. Dermatol. – 2004; 51: 440–7.

183.Pascal J. The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis // J. Am. Acad. Dermatol. – 2006; 55: 632–6.

184.Paus R., Heinzelmann T., Robiscek S. et al. Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ // Arch. Dermatol. Res. – 1995; 287: 500–2.

185.Paus R., Nickoloff B.J., Ito T. A “hairy”privilege // Trends Immunol. – 2005; 26: 32–40.

186.Paus R., Peters E.M., Eichmüller S. et al. Neural mechanisms of hair growth control // J. Invest. Dermatol. Symp. Proc. – 1997; 2: 61–8.

187.Paus R., Slominski A., Czarnetzki B.M. Is alopecia areata an autoimmuneresponse against melanogenesis-related proteins, exposed by abnormal MHC class I

Med. – 1994; 66: 541–54.

188.Pelivani N., Hassan A.S., Braathen L.R. et al. Alopecia areata universalis elicited during treatment with adalimumab // Dermatology. – 2008; 216 (4): 320–3.

189.Perret C., Wiesner-Mensel L., Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata // Acta Derm. Venereol. (Stockh). – 1984; 64: 26–30.

190.Peters E.M., Botchkarev V.A., Botchkareva N.V. et al. Hair-cycle- associated remodeling of the peptidergic innervation of murine skin, and hair growth